Sermorelin has moved from longevity-clinic menus into mainstream telehealth, and with that comes a lot of confused marketing — it gets described as "HGH therapy," "a natural HGH alternative," or "a growth hormone peptide," none of which is quite right. This is a plain-English guide to what sermorelin actually is, how it differs from growth hormone itself, where it stands legally, and what a legitimate, clinician-prescribed program looks like.
The short version: sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) — the signal the body uses to prompt the pituitary gland's own growth hormone release. It is not growth hormone, and it is not an HGH replacement. It's prescription-only, prepared by compounding pharmacies, and appropriate only for some adults — a determination a licensed clinician makes from your health history.
What sermorelin is, mechanically
Your body regulates growth hormone through a signaling chain: the hypothalamus releases growth hormone-releasing hormone (GHRH), which tells the pituitary gland to produce and release growth hormone in pulses. Natural growth hormone levels decline as we age.
Sermorelin is a synthetic peptide analog of the first 29 amino acids of GHRH — the fragment responsible for that signal. Taken as a small subcutaneous injection, it acts on the pituitary gland to encourage the body's own growth hormone release, working within the body's existing regulatory feedback loops rather than adding external growth hormone to them.
That "works upstream" distinction is the whole story of what sermorelin is — and it's why the next section matters.
Sermorelin vs. HGH: not the same thing, not a substitute
Human growth hormone (HGH, somatropin) therapy supplies the hormone itself, directly. It is an FDA-approved treatment for specific diagnosed conditions — such as growth hormone deficiency — and its use outside those indications is both medically and legally fraught.
Sermorelin is a different molecule doing a different job: it's the signal, not the hormone. A few practical differences follow from that:
| Sermorelin | HGH (somatropin) | |
|---|---|---|
| What it is | A synthetic analog of GHRH, the releasing signal | The growth hormone itself |
| How it acts | Encourages the pituitary's own production pathways | Supplies the hormone directly, bypassing them |
| Regulatory status | Compounded per-patient by licensed pharmacies; not FDA-approved | FDA-approved for specific diagnosed conditions |
| How it's prescribed | By a licensed clinician, when clinically appropriate | By a physician for a qualifying diagnosis |
To be explicit about what this table does not say: sermorelin is not "milder HGH," not "natural HGH," and not a workaround for people who don't qualify for growth hormone therapy. They are different medications with different clinical reasoning behind them, and a clinician — not marketing copy — determines whether either is appropriate for a given patient.
Is sermorelin FDA-approved? The regulatory picture, honestly
Compounded sermorelin is prepared per-patient by state-licensed US compounding pharmacies against a clinician's prescription — and it is not FDA-approved. That's a factual status worth understanding rather than glossing over: it means sermorelin hasn't gone through the FDA's drug-approval process for a labeled indication, and it's exactly why a legitimate program gates everything behind a licensed clinician's review.
This also puts sermorelin in a completely different category from the "research use only" compounds sold by online vendors — a sermorelin prescription runs through a licensed clinician and a licensed, state-regulated pharmacy, with a named provider accountable for the decision. If you want the full legal map of how peptide-class compounds are regulated, see Are peptides legal? FDA rules explained.
One more boundary worth stating plainly: sermorelin is not a weight-loss medication. If that's the goal you're researching, the evidence-backed peptide-class medications are GLP-1s — we cover that honestly in Peptides for weight loss: what actually works.
Who sermorelin is — and isn't — appropriate for
Whether sermorelin is appropriate for you is a clinical decision, made by a US-licensed clinician from your health history and goals. It isn't right for everyone. Per our clinical partner's prescribing criteria, the program is available to adults 55 and under, and certain conditions mean it isn't an appropriate treatment — including pregnancy, planned pregnancy, or breastfeeding; active cancer; pituitary disease; untreated hypothyroidism; uncontrolled diabetes; an intracranial lesion; and heart failure.
A responsible program screens for all of this before anything is prescribed — and tells you clearly when it's not a fit.
See if sermorelin is appropriate for you
A US-licensed clinician reviews your health history and determines whether sermorelin is clinically appropriate — and tells you honestly if it isn't.
Start your intake →What a clinician-prescribed sermorelin program looks like
A legitimate telehealth sermorelin program follows the same shape as any real telehealth care:
- An online intake covering your health history, medications, allergies, and goals.
- A US-licensed clinician reviews it and decides whether sermorelin is clinically appropriate for you.
- If prescribed, a US-licensed compounding pharmacy prepares it and ships it to your door, with instructions for the small subcutaneous injection.
- Ongoing check-ins and messaging with your care team as you go.
At Pallas, the sermorelin program is $89 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. That's one all-in price — clinician care, check-ins, care-team messaging, and your medication when prescribed, with free shipping from a US-licensed pharmacy. The full program details are at our sermorelin program page, and the step-by-step process is covered in how to get sermorelin prescribed online.
Frequently asked questions
Frequently asked questions
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) — the signal the hypothalamus sends to prompt the pituitary gland's own growth hormone release. Taken as a small subcutaneous injection, it acts on the pituitary to encourage the body's own production pathways. Natural growth hormone levels decline with age; whether sermorelin is appropriate for you is determined by a US-licensed clinician.
No. HGH therapy supplies growth hormone directly; sermorelin is the releasing signal, working upstream by encouraging the pituitary gland's own production. Sermorelin is not growth hormone, not an HGH replacement, and not a "milder" or "natural" version of it — they're different medications with different clinical reasoning behind them.
As a small subcutaneous injection — under the skin, with a fine needle — with dosing personalized by your prescribing clinician. Your care team provides instructions with your shipment and is available by secure message for questions.
Per our clinical partner's prescribing criteria, the program is available to adults 55 and under, and sermorelin isn't an appropriate treatment for people who are pregnant, planning pregnancy, or breastfeeding, or who have active cancer, pituitary disease, untreated hypothyroidism, uncontrolled diabetes, an intracranial lesion, or heart failure. A US-licensed clinician screens for all of this during intake — eligibility is always a clinical decision.
At Pallas, the sermorelin program is $89 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. One all-in price covers your clinician, ongoing check-ins, care-team messaging, and your medication when prescribed, with free shipping from a US-licensed pharmacy. If a clinician decides treatment isn't right for you, you're refunded in full.